Evaxion A (EVAX) Prepaid Assets (2019 - 2025)
Evaxion A's (EVAX) quarterly Prepaid Assets came in at $801000.0 in Q4 2025, down 37.08% YoY from $1.3 million in Q4 2024, and down 68.8% on a QoQ basis from $2.6 million in Q2 2025.
Evaxion A (EVAX) Prepaid Assets (2019 - 2025) Analysis & Trends
Evaxion A (EVAX) has 7 years of Prepaid Assets data on file, last reported at $801000.0 in Q4 2025.
- Quarterly Prepaid Assets fell 37.08% year-over-year to $801000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $801000.0 (down 37.08% YoY) and the FY2025 annual result came in at $801000.0, down 37.08% from the prior year.
- Prepaid Assets retreated to $801000.0 in Q4 2025, from $2.6 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $3.9 million in Q1 2021 to a low of $801000.0 in Q4 2025.
- A 5-year average of $2.2 million and a median of $2.2 million in 2021 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 145.25% — and 2024, when it plunged 42.47%.
- Tracing EVAX's Prepaid Assets over 5 years: stood at $1.1 million in 2021, then surged by 145.25% to $2.8 million in 2022, then plunged by 30.06% to $2.0 million in 2023, then sank by 34.78% to $1.3 million in 2024, then sank by 37.08% to $801000.0 in 2025.
- The last three Prepaid Assets figures came in at $801000.0 (Q4 2025), $2.6 million (Q2 2025), and $1.3 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Evaxion A | 27.61 Mn | 27.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 801,000.00 |
| Jun 30, 2025 | 2.57 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Dec 31, 2023 | 1.95 Mn |
| Jun 30, 2023 | 3.33 Mn |
| Dec 31, 2022 | 2.79 Mn |
| Jun 30, 2022 | 1.89 Mn |
| Mar 31, 2022 | 2.58 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 2.20 Mn |
| Jun 30, 2021 | 2.56 Mn |
| Mar 31, 2021 | 3.90 Mn |
| Dec 31, 2020 | 1.55 Mn |
| Dec 31, 2019 | 575,000.00 |